Alterations of Gut Microbiota and the Brain-Immune-Intestine Axis in Patients With Relapsing-Remitting Multiple Sclerosis After Treatment With Oral Cladribine: Protocol for a Prospective Observational Study
Alterations of Gut Microbiota and the Brain-Immune-Intestine Axis in Patients With Relapsing-Remitting Multiple Sclerosis After Treatment With Oral Cladribine: Protocol for a Prospective Observational Study
Jeske van Pamelen
1
, MD ;
Lynn van Olst
2
, MSc ;
Andries E Budding
3
, MD, PhD ;
BIA Study Group
4
;
Helga E de Vries
2, 5
, PhD ;
Leo H Visser
1
, MD, PhD
1
Department of Neurology, Elisabeth-TweeSteden Ziekenhuis Hospital, Tilburg, Netherlands
2
Department of Molecular Cell Biology and Immunology, MS Center Amsterdam, Amsterdam University Medical Centers, Amsterdam, Netherlands
3
inBiome, Amsterdam, Netherlands
4
see Acknowledgements, Netherlands
5
Department of Medical Biochemistry, Amsterdam Cardiovascular Sciences, University of Amsterdam, Amsterdam, Netherlands
Corresponding Author:
-
Jeske van Pamelen, MD
-
Department of Neurology
-
Elisabeth-TweeSteden Ziekenhuis Hospital
-
Hilvarenbeekseweg 60
-
Tilburg, 5022GC
-
Netherlands
-
Phone:
31 132212552
-
Email: j.vanpamelen@etz.nl